SEATTLE, Oct. 14, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV). Over the last 12 months we have made significant progress in moving TapImmune and its technology platform toward the clinic. This Corporate Update quantifies recent announcements in the context of our overall strategy.
